Related references
Note: Only part of the references are listed.Premedication Does Not Influence the Incidence of Infliximab Infusion Reactions in Pediatric Patients with Inflammatory Bowel Disease-A Single Center Case-Control Study
Edyta Szymanska et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Real-World Experience With Acute Infusion Reactions to Ustekinumab at 2 Large Tertiary Care Centers
Elizabeth A. Spencer et al.
CROHNS & COLITIS 360 (2020)
Premedication with intravenous steroids does not influence the incidence of infusion reactions following infliximab infusions in pediatric inflammatory bowel disease patients-a case-control study
Elsa A. van Wassenaer et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Incidence and Management of Infusion Reactions to Infliximab in an Alternate Care Setting
L. Allyson Checkley et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Safety of Oral and Intravenous Iron
Thomas G. DeLoughery
ACTA HAEMATOLOGICA (2019)
Adverse Reactions After Intravenous Iron Infusion Among Inflammatory Bowel Disease Patients in the United States, 2010-2014
Eboselume Akhuemonkhan et al.
INFLAMMATORY BOWEL DISEASES (2018)
Five-Year Period Prevalence and Characteristics of Anemia in a Large US Inflammatory Bowel Disease Cohort
Ioannis E. Koutroubakis et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2016)
Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Stefanos Bonovas et al.
MEDICINE (2016)
European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases
Axel U. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2015)
Safety of Ferric Carboxymaltose Immediately after Infliximab Administration, in a Single Session, in Inflammatory Bowel Disease Patients with Iron Deficiency: A Pilot Study
Xavier Cortes et al.
PLOS ONE (2015)
Prevalence of Anemia in Inflammatory Bowel Diseases in European Countries: A Systematic Review and Individual Patient Data Meta-analysis
Natalie Filmann et al.
INFLAMMATORY BOWEL DISEASES (2014)
Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2)
Shawn N. Murphy et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2010)
Risks and benefits of biologic therapy for inflammatory bowel diseases
Geert D'Haens
GUT (2007)
Prevalence and outcomes of anemia in inflammatory bowel disease: A systematic review of the literature
A Wilson et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Intravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementation
JC Barton et al.
AMERICAN JOURNAL OF MEDICINE (2000)
Share Paper
